Credit Suisse’s TELA Bio TELA Stock Holding History

Credit Suisse’s Portfolio TELA Stock Details TELA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-20,600	Closed	-$161K	–	4133
2020 Q1	$161K	Buy	20,600 +9,700	+89%	+$131K	﹤0.01%	3716
2019 Q4	$141K	Buy	+10,900	New	+$133K	﹤0.01%	4039

Other funds holding TELA

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Essex Woodlands Management The Woodlands, Texas $251M AUM 13.72% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Alyeska Investment Group

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return

Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Sanders Morris Harris Houston, Texas $172M AUM 22.54% 1-Year Est. Return

Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return

Credit Suisse's TELA Position: Q2 2020 in Review

Credit Suisse sold out of TELA Bio (TELA) in Q2 2020, closing a stake of 20,600 shares — an estimated $161K sold.

Credit Suisse first reported a position in TELA in Q4 2019 and held it in 2 quarters. The position peaked at $161K in Q1 2020. 49 funds tracked by Wall St. Rank hold TELA as of Q2 2020.

Credit Suisse reported no remaining TELA Bio position as of Q2 2020 after selling out during the quarter.
Credit Suisse sold 20,600 TELA Bio shares in Q2 2020, an estimated $161K.
Credit Suisse first reported a position in TELA Bio in Q4 2019 and held it in 2 quarters.
Credit Suisse's TELA Bio position peaked at $161K in Q1 2020.
49 funds tracked by Wall St. Rank held TELA Bio as of Q2 2020.

Based on Credit Suisse's 13F filing for Q2 2020, filed 12 Aug 2020.